Clinical trial design for non-muscle-invasive bladder cancer

被引：3
|
作者：
Tan, Wei Shen [1 ,2 ]
Hall, Emma [3 ]
Kamat, Ashish M. [1 ]
Kelly, John D. [2 ,4 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[2] UCL, Div Surg & Intervent Sci, London, England
[3] Inst Canc Res, Clin Trials & Stat Unit, London, England
[4] Univ Coll London Hosp, Dept Urol, London, England
来源：
NATURE REVIEWS UROLOGY | 2023年 / 20卷 / 10期
关键词：
D O I：
10.1038/s41585-023-00789-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The heterogeneous nature of non-muscle-invasive bladder cancer is a challenge for clinical trial design. Careful consideration in clinical trial design, choice of end points and adequate patient characterization is important when evaluating new therapies.
引用
收藏
页码：575 / 576
页数：2
相关论文
共 50 条
  • [21] Transurethral Resection of Non-muscle-invasive Bladder Cancer
    Babjuk, Marko
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (07) : 542 - 548
  • [22] Management of Non-Muscle-Invasive (Superficial) Bladder Cancer
    Nargund, Vinod H.
    Tanabalan, C. K.
    Kabir, M. N.
    SEMINARS IN ONCOLOGY, 2012, 39 (05) : 559 - 572
  • [23] Non-muscle-invasive bladder cancer: a vision for the future
    Malmstrom, Per-Uno
    Agrawal, Sachin
    Blackberg, Mats
    Bostrom, Peter J.
    Malavaud, Bernard
    Zaak, Dirk
    Hermann, Gregers G.
    SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 (02) : 87 - 94
  • [24] Intravesical treatment of non-muscle-invasive bladder cancer
    Bahlburg, Henning
    Noldus, Joachim
    Roghmann, Florian
    UROLOGIE, 2025,
  • [25] Mutational landscape of non-muscle-invasive bladder cancer
    Hurst, Carolyn D.
    Knowles, Margaret A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (07) : 295 - 303
  • [26] Intravesical chemotherapy in non-muscle-invasive bladder cancer
    Porten, Sima P.
    Leapman, Michael S.
    Greene, Kirsten L.
    INDIAN JOURNAL OF UROLOGY, 2015, 31 (04) : 297 - 303
  • [27] Current management of non-muscle-invasive bladder cancer
    Rodriguez Faba, O.
    Gaya, J. M.
    Lopez, J. M.
    Capell, M.
    De Gracia-Nieto, A. E.
    Gomez Correa, E.
    Breda, A.
    Palou, J.
    MINERVA MEDICA, 2013, 104 (03) : 273 - 286
  • [28] New therapies for non-muscle-invasive bladder cancer
    Chiong, Edmund
    Esuvaranathan, Kesavan
    WORLD JOURNAL OF UROLOGY, 2010, 28 (01) : 71 - 78
  • [29] Guideline of guidelines: non-muscle-invasive bladder cancer
    Woldu, Solomon L.
    Bagrodia, Aditya
    Lotan, Yair
    BJU INTERNATIONAL, 2017, 119 (03) : 371 - 380
  • [30] Clinical and pathohistological risk factors of relapse in non-muscle-invasive bladder cancer
    Mikhaleva, L.
    Gusniev, M.
    Pechnikova, V.
    Akopyan, E.
    Vasyukova, O.
    Midiber, K.
    Vandysheva, R.
    Kamalov, A.
    Pshikhachev, A.
    VIRCHOWS ARCHIV, 2021, 479 : S176 - S176
12345